Author Archive

Bio-Industry leader Dr Louis J Nisbet leads BioCity forward

| November 22, 2011 | 0 Comments

New Chairman of BioCity Nottingham Louis J Nisbet DSc PhD assumes his position this month amidst significant changes and challenges in the global life sciences sector.

Filed Under: BioCity Nottingham

Variety and Success marks ‘The Year in Industry’ 25 Year Celebration

| November 21, 2011 | 0 Comments

A small celebratory publication gives an interesting snapshot of careers in the engineering industry over the last 25 years. The charity EDT has published the booklet to mark 25 years of their well known “The Year in Industry” (YINI) gap year programme for engineers and scientists. EDT has gone on the hunt for former students and the book gives a brief outline of some of their careers since their placement year before university. The book is sponsored by The Royal Academy of Engineering and forms part of The Year in Industry’s 25th Anniversary Celebrations sponsored by The Lloyd’s Register Educational Trust.

Filed Under: EDT National

Sygnature Discovery: New Bioscience Group Fully-Operational & Winning Projects

| November 21, 2011 | 0 Comments

Sygnature Discovery, a leading provider of integrated drug discovery services to the pharmaceutical industry, has today provided an up-date on its new Bioscience group. The team was established in August 2011 and is already involved in a number of drug discovery activities for clients, including integrated discovery projects and in vitro biology-only projects.

Filed Under: Sygnature Discovery

Giving World Online goes nationwide with University of Leicester expertise

| November 17, 2011 | 0 Comments

Leicester-based social enterprise Giving World Online is ready to expand its operations across the UK, bringing relief to thousands more vulnerable and disadvantaged communities thanks to technical expertise, advice and contacts provided by the University of Leicester.

BioCity attracts AstraZeneca and Pfizer entrepreneurs

| November 16, 2011 | 0 Comments

Six brand new companies started by former AstraZeneca Charnwood employees will create a total of 15 jobs within BioCity Nottingham by the end of November this year, contributing to the total of 35 new jobs created at BioCity out of the global pharmaceutical giant’s closure of the East Midlands’ site. In addition, top scientists leaving Pfizer in Sandwich are starting to enquire about BioCity support with the first virtual tenant recently confirmed.

Filed Under: BioCity Nottingham

New Findings Show Business Failure Doesn’t Always Teach Subsequent Success

| November 7, 2011 | 0 Comments

The popularist view that business failure often provides the basis for subsequent entrepreneurial success has been brought into question with the release of new research led by Prof. Colin Mason of the University of Strathclyde. The full findings of the research will be unveiled at the Institute for Small Business and Entrepreneurship (IBSE) Conference in Sheffield on Wednesday 9th November.

Filed Under: Colin Mason

Advice in BEM magazine – Writing an effective press release

| November 1, 2011 | 0 Comments

At Integra we recognise that young businesses often can’t justify spending money on a PR agency. We are happy to give good advice anyway as, once a company gets busier they will realise that they don’t have time to do it themselves but will know how valuable PR can be. That is why we speak [...]

Filed Under: PR Practice

Where Art Meets Science competition opens to Leicestershire art students

| October 31, 2011 | 0 Comments

Leicestershire’s creative students will have the opportunity to showcase their work in a two-week exhibition in the heart of Leicester’s cultural quarter as part of the 2012 Healthcare and Bioscience iNet competition ‘Where Art Meets Science’.

Sygnature Discovery and Saretius Establish Strategic Alliance

| October 31, 2011 | 0 Comments

Sygnature Discovery, a leading provider of integrated drug discovery services to the pharmaceutical industry, and Saretius, a pre-clinical experimental services company offering ‘gold standard’ techniques in pain, metabolic and CNS disorders, inflammatory disease and in vivo pharmacokinetics, today announced they have entered into a strategic alliance.

Filed Under: Sygnature Discovery

Social Media Hacking

| October 26, 2011 | 0 Comments

What are we doing to protect our social media reputations?

Filed Under: Online PR